These findings demonstrated the participation of HDAC1 in suppressing IGF1 expression in PCa and suggested that inhibition of HDAC1 might lead to increased STAT3 activity and cell invasive ability, and, therefore, this may be a concern for the potential application of HDAC inhibitors in PCa treatment. This evidence concerns the gene STAT3 and posterior cortical atrophy.